Celularity Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Celularity Inc. on October 21, 2024, reporting events occurring on October 18, 2024. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in Florham Park, New Jersey. Its Class A Common Stock (CELU) and Warrants (CELUW) are listed on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status regarding stock exchange listing requirements.
Material Changes and Listing Status
- Delisting Notice: Celularity received notice from Nasdaq on October 16, 2024, that it failed to regain compliance with Nasdaq Listing Rule 5250(c)(1) by the October 14, 2024 deadline.
- Cause of Non-Compliance: The failure stems from the company's inability to timely file Quarterly Reports on Form 10-Q for the periods ended March 31, 2024, and June 30, 2024.
- Trading Suspension: Unless an appeal is filed by October 23, 2024, trading of the company's securities will be suspended on The Nasdaq Capital Market at the opening of business on October 25, 2024.
- Current Status: As of the filing date, the notice has no immediate effect, and securities continue to trade under symbols CELU and CELUW.
Outlook, Risks, and Management Commentary
Management intends to file an appeal with a Nasdaq Hearings Panel pursuant to the Nasdaq Listing Rule 5800 Series. The company is evaluating options to regain compliance. However, the filing explicitly states there can be no assurance that the appeal will be filed, that it will be successful, or that the company will regain or maintain compliance with Nasdaq listing requirements.
Investor Verification Checklist
- Verify if Celularity filed an appeal with the Nasdaq Hearings Panel by the October 23, 2024 deadline.
- Confirm the status of the missing Form 10-Q filings for the quarters ended March 31, 2024, and June 30, 2024.
- Monitor trading status on October 25, 2024, to determine if the suspension of trading on The Nasdaq Capital Market has been enacted.
- Review any subsequent 8-K filings regarding the outcome of the appeal or alternative compliance plans.